| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Gonçalo Moniz Research Center - Fundaçào Oswaldo Cruz, Salvador, Bahia, Brazil
Chronic chagasic cardiomyopathy (CChC) is characterized by an inflammatory reaction which may eventually lead to heart enlargement, arrythmia, and death. As described herein, interleukin-4-deficient mice mount increased specific T helper (Th) 1 immune responses when infected with Trypanosoma cruzi, as compared to wild-type mice. Interestingly, these mice had reduced parasitism and mortality and exacerbated inflammation in their hearts, demonstrating a clear dissociation between inflammation and parasite load. The modulation of these phenomena so as to maximize host and parasite survivals may depend on a fine balance between Th responses, in which a Th1 response will, on one hand, control parasitism and, on the other hand, enhance heart inflammation throughout the course of the infection.
This article has been cited by other articles:
![]() |
V. Galvao, J. G. V. Miranda, and R. Ribeiro-dos-Santos Development of a two-dimensional agent-based model for chronic chagasic cardiomyopathy after stem cell transplantation Bioinformatics, September 15, 2008; 24(18): 2051 - 2056. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. S. Gomes, L. M. G. Bahia-Oliveira, M. O. C. Rocha, S. C. U. Busek, M. M. Teixeira, J. S. Silva, and R. Correa-Oliveira Type 1 Chemokine Receptor Expression in Chagas' Disease Correlates with Morbidity in Cardiac Patients Infect. Immun., December 1, 2005; 73(12): 7960 - 7966. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Cunha-Neto, V. J. Dzau, P. D. Allen, D. Stamatiou, L. Benvenutti, M. L. Higuchi, N. S. Koyama, J. S. Silva, J. Kalil, and C.-C. Liew Cardiac Gene Expression Profiling Provides Evidence for Cytokinopathy as a Molecular Mechanism in Chagas' Disease Cardiomyopathy Am. J. Pathol., August 1, 2005; 167(2): 305 - 313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Garcia, C. O. Ramos, J. F. V. Senra, F. Vilas-Boas, M. M. Rodrigues, A. C. Campos-de-Carvalho, R. Ribeiro-dos-Santos, and M. B. P. Soares Treatment with Benznidazole during the Chronic Phase of Experimental Chagas' Disease Decreases Cardiac Alterations Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1521 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Leon, K. Wang, and D. M. Engman Myosin Autoimmunity Is Not Essential for Cardiac Inflammation in Acute Chagas' Disease J. Immunol., October 15, 2003; 171(8): 4271 - 4277. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. S. Gomes, L. M. G. Bahia-Oliveira, M. O. C. Rocha, O. A. Martins-Filho, G. Gazzinelli, and R. Correa-Oliveira Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response Infect. Immun., March 1, 2003; 71(3): 1185 - 1193. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Michailowsky, N. M. Silva, C. D. Rocha, L. Q. Vieira, J. Lannes-Vieira, and R. T. Gazzinelli Pivotal Role of Interleukin-12 and Interferon-{gamma} Axis in Controlling Tissue Parasitism and Inflammation in the Heart and Central Nervous System during Trypanosoma cruzi Infection Am. J. Pathol., November 1, 2001; 159(5): 1723 - 1733. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |